Progenity Inc. [NASDAQ: PROG] loss -0.52% or -0.01 points to close at $1.91 with a heavy trading volume of 12019644 shares. The company report on January 5, 2022 that Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO’22.
Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today announced that two presentations with patient data on indicators of efficacy in the treatment of gastrointestinal disorders have been accepted by the 17th Congress of the European Crohn’s and Colitis Organisation (ECCO), February 16-19, 2022, the world’s largest forum for IBD specialists. ECCO’s mission is to improve the care of patients with IBD through international guidelines, education, research, and collaboration.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
It opened the trading session at $1.90, the shares rose to $1.95 and dropped to $1.79, the range by which the price of stock traded the whole day. The daily chart for PROG points out that the company has recorded -33.68% loss over the past six months. However, it is still -189.39% lower than its most recent low trading price.
If we look at the average trading volume of 70.38M shares, PROG reached to a volume of 12019644 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Progenity Inc. [PROG]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PROG shares is $3.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PROG stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Stephens have made an estimate for Progenity Inc. shares, keeping their opinion on the stock as Equal-Weight, with their previous recommendation back on November 04, 2021. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on October 14, 2021, representing the official price target for Progenity Inc. stock. Previously, the target price had yet another drop from $4 to $2, while Robert W. Baird kept a Neutral rating on PROG stock. On February 08, 2021, analysts decreased their price target for PROG shares from 11 to 5.
The Average True Range (ATR) for Progenity Inc. is set at 0.27, with the Price to Sales ratio for PROG stock in the period of the last 12 months amounting to 21.36.
Trading performance analysis for PROG stock
Progenity Inc. [PROG] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -15.11. With this latest performance, PROG shares dropped by -24.80% in over the last four-week period, additionally sinking by -33.68% over the last 6 months – not to mention a drop of -69.59% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PROG stock in for the last two-week period is set at 36.05, with the RSI for the last a single of trading hit 31.45, and the three-weeks RSI is set at 39.98 for Progenity Inc. [PROG]. The present Moving Average for the last 50 days of trading for this stock 2.9518, while it was recorded at 2.0280 for the last single week of trading, and 2.5634 for the last 200 days.
Progenity Inc. [PROG]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Progenity Inc. [PROG] shares currently have an operating margin of -561.13 and a Gross Margin at -129.20. Progenity Inc.’s Net Margin is presently recorded at -472.30.
Return on Total Capital for PROG is now -1,020.81, given the latest momentum, and Return on Invested Capital for the company is -890.01. Additionally, PROG Total Debt to Total Capital is recorded at 293.42, with Total Debt to Total Assets ending up at 105.10.
Receivables Turnover for the company is 2.30 with a Total Asset Turnover recorded at a value of 0.32.Progenity Inc.’s liquidity data is similarly interesting compelling, with a Current Ratio set at 0.90.
An analysis of insider ownership at Progenity Inc. [PROG]
There are presently around $92 million, or 53.00% of PROG stock, in the hands of institutional investors. The top three institutional holders of PROG stocks are: ATHYRIUM CAPITAL MANAGEMENT, LP with ownership of 36,396,907, which is approximately 0% of the company’s market cap and around 10.50% of the total institutional ownership; NEUBERGER BERMAN GROUP LLC, holding 6,541,060 shares of the stock with an approximate value of $12.49 million in PROG stocks shares; and VANGUARD GROUP INC, currently with $1.77 million in PROG stock with ownership of nearly 1.778% of the company’s market capitalization.
Positions in Progenity Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 23 institutional holders increased their position in Progenity Inc. [NASDAQ:PROG] by around 2,594,549 shares. Additionally, 22 investors decreased positions by around 9,716,668 shares, while 9 investors held positions by with 35,611,610 shares. The mentioned changes placed institutional holdings at 47,922,827 shares, according to the latest SEC report filing. PROG stock had 12 new institutional investments in for a total of 1,663,853 shares, while 18 institutional investors sold positions of 9,580,159 shares during the same period.